Reid G. Adler
General Counsel, Vistagen Therapeutics, Inc.
Companies
- Vistagen Therapeutics, Inc.General counsel May 3, 2022 to now1
- Vistagen Therapeutics, Inc.CHF CORP DEVEL OFF, GEN COUNS Jan 3, 2024 to Jul 2, 20242
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Vistagen Therapeutics, Inc. VTGN60,868 shares3$12.4K at $0.20Jun 30, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Jun 30, 2026Granted 36,818 shares at $0.19 of Vistagen Therapeutics, Inc.3
- Jun 30, 2025Granted 7,541 shares at $1.70 of Vistagen Therapeutics, Inc.4
- Jun 28, 2024Granted 4,854 shares at $2.96 of Vistagen Therapeutics, Inc.5
- Dec 29, 2023Granted 167 shares at $1.72 of Vistagen Therapeutics, Inc.6
- Jun 30, 2023Granted 167 shares at $1.59 of Vistagen Therapeutics, Inc.7
- Aug 17, 2022Bought 300,000 shares at $0.17 of Vistagen Therapeutics, Inc.8
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4SEC EDGARForm 4 filed Jul 1, 2025
- 5SEC EDGARForm 4 filed Jul 2, 2024
- 6SEC EDGARForm 4 filed Jan 3, 2024
- 7SEC EDGARForm 4 filed Jul 5, 2023
- 8SEC EDGARForm 4 filed Aug 19, 2022